NajarianJS, SutherlandDE, BaumgartnerD, BurkeB, RynasiewiczJJ, MatasAJ, GoetzFC.Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg1980;192:526–542.
2.
WahoffDC, PapaloisBE, NajarianJS, KendallDM, FarneyAC, LeoneJP, JessurunJ, DunnDL, RobertsonRP, SutherlandDE.Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg1995;222:562–579.
3.
PyzdrowskiKL, KendallDM, HalterJB, NakhlehRE, SutherlandDE, RobertsonRP.Preserved insulin secretion and insulin independence in recipients of islet autografts [see comments]. N Engl J Med1992;327:220–226.
4.
TeuscherAU, KendallDM, SmetsYF, LeoneJP, SutherlandDE, RobertsonRP.Successful islet autotransplantation in humans: Functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes1998;47:324–330.
5.
RobertsonRP, LanzKJ, SutherlandDE, KendallDM.Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes2001;50:47–50.
6.
RobertsonRP, LanzKJ, SutherlandDE, SeaquistER.Beta cell function and glycemic control 9-18 years after hemipancreatectomy and transplantation in donors and recipients: Relationship between diabetes and obesity. Transplantation 2001; In Press.
7.
KendallDM, TeuscherAU, RobertsonRP.Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes1997;46:23–27.
8.
GuptaV, WahoffDC, RooneyDP, PoitoutV, SutherlandDE, KendallDM, RobertsonRP.The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes1997;46:28–33.
